Skip Page Header

Home > Making the investment case: cost-effectiveness evidence for harm reduction.

Harm Reduction International. (2020) Making the investment case: cost-effectiveness evidence for harm reduction. London: Harm Reduction International.

[img]
Preview
PDF (Making the investment case: Cost-effectiveness evidence for harm reduction) - Published Version
261kB

In an era of shrinking international funding to address HIV, hepatitis C (HCV) and tuberculosis (TB), and competing priorities for domestic investment in health programmes, there is growing emphasis on ensuring value for money, efficient allocation of resources, and cost-effectiveness.

Repository Staff Only: item control page